BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 11520143)

  • 1. Tumor diameter and volume assessed by magnetic resonance imaging in the prediction of outcome for invasive cervical cancer.
    Wagenaar HC; Trimbos JB; Postema S; Anastasopoulou A; van der Geest RJ; Reiber JH; Kenter GG; Peters AA; Pattynama PM
    Gynecol Oncol; 2001 Sep; 82(3):474-82. PubMed ID: 11520143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretreatment tumour volume measurement on high-resolution magnetic resonance imaging as a predictor of survival in cervical cancer.
    Soutter WP; Hanoch J; D'Arcy T; Dina R; McIndoe GA; DeSouza NM
    BJOG; 2004 Jul; 111(7):741-7. PubMed ID: 15198766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor volume and uterine body invasion assessed by MRI for prediction of outcome in cervical carcinoma treated with concurrent chemotherapy and radiotherapy.
    Kim H; Kim W; Lee M; Song E; Loh JJ
    Jpn J Clin Oncol; 2007 Nov; 37(11):858-66. PubMed ID: 18037686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The validity of tumour diameter assessed by magnetic resonance imaging and gross specimen with regard to tumour volume in cervical cancer patients.
    Jung DC; Ju W; Choi HJ; Kang S; Park S; Yoo CW; Park SY
    Eur J Cancer; 2008 Jul; 44(11):1524-8. PubMed ID: 18573655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is there a benefit of pretreatment laparoscopic transperitoneal surgical staging in patients with advanced cervical cancer?
    Marnitz S; Köhler C; Roth C; Füller J; Hinkelbein W; Schneider A
    Gynecol Oncol; 2005 Dec; 99(3):536-44. PubMed ID: 16126259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathologic score predicts recurrence free survival after radical surgery in patients with stage IA2-IB1-2 cervical carcinoma.
    Grisaru DA; Covens A; Franssen E; Chapman W; Shaw P; Colgan T; Murphy J; DePetrillo D; Lickrish G; Laframboise S; Rosen B
    Cancer; 2003 Apr; 97(8):1904-8. PubMed ID: 12673716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference?
    Rutledge TL; Kamelle SA; Tillmanns TD; Gould NS; Wright JD; Cohn DE; Herzog TJ; Rader JS; Gold MA; Johnson GA; Walker JL; Mannel RS; McMeekin DS
    Gynecol Oncol; 2004 Oct; 95(1):70-6. PubMed ID: 15385112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of tumor volume in cervical cancer by magnetic resonance imaging.
    Narayan K; McKenzie A; Fisher R; Susil B; Jobling T; Bernshaw D
    Am J Clin Oncol; 2003 Oct; 26(5):e163-8. PubMed ID: 14528092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation using magnetic resonance imaging for patients with stage III cervical carcinoma treated by radiation alone in multicenter analysis: its usefulness and limitations in clinical practice.
    Kodaira T; Fuwa N; Toita T; Nomoto Y; Kuzuya K; Tachibana K; Furutani K; Ogawa K
    Am J Clin Oncol; 2003 Dec; 26(6):574-83. PubMed ID: 14663375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of clinically established MRI procedures concerning the pretherapeutic evaluation of maximal tumor diameter in primary or recurrent cervix cancer in relation to palpation findings and histopathologic whole mount specimens].
    Schäffer U; Hawighorst H; Pilch H; Weikel W; Zuna I; Knapstein PG
    Zentralbl Gynakol; 1999; 121(3):131-6. PubMed ID: 10209855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of patients after extraperitoneal lymph node dissection for cervical cancer.
    Denschlag D; Gabriel B; Mueller-Lantzsch C; Tempfer C; Henne K; Gitsch G; Hasenburg A
    Gynecol Oncol; 2005 Mar; 96(3):658-64. PubMed ID: 15721408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical cancer: value of an endovaginal coil magnetic resonance imaging technique in detecting small volume disease and assessing parametrial extension.
    deSouza NM; Dina R; McIndoe GA; Soutter WP
    Gynecol Oncol; 2006 Jul; 102(1):80-5. PubMed ID: 16427688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognostic impact of tumour volume and lymph node involvement in intermediate stage T1b1 to T2b cancer of the uterine cervix].
    Goudy G; Stoeckle E; Thomas L; Kind M; Guyon F; Brouste V; Floquet A
    Bull Cancer; 2009 Jun; 96(6):685-94. PubMed ID: 19467961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognostic factors of stage IB and IIA carcinoma of the cervix treated by surgery].
    Zhang WH; Wu LY; Bai P; Li SM; Zhang R; Li B; Sun JH; Wu AR
    Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):490-2. PubMed ID: 15555341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How important is removal of the parametrium at surgery for carcinoma of the cervix?
    Covens A; Rosen B; Murphy J; Laframboise S; DePetrillo AD; Lickrish G; Colgan T; Chapman W; Shaw P
    Gynecol Oncol; 2002 Jan; 84(1):145-9. PubMed ID: 11748991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer.
    Pötter R; Dimopoulos J; Georg P; Lang S; Waldhäusl C; Wachter-Gerstner N; Weitmann H; Reinthaller A; Knocke TH; Wachter S; Kirisits C
    Radiother Oncol; 2007 May; 83(2):148-55. PubMed ID: 17531904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of prognostic factors for uterine cervical cancer patients treated with irradiation alone.
    Grigiene R; Valuckas KP; Aleknavicius E; Kurtinaitis J; Letautiene SR
    BMC Cancer; 2007 Dec; 7():234. PubMed ID: 18154683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small FIGO stage IB cervical cancer.
    Girardi F; Burghardt E; Pickel H
    Gynecol Oncol; 1994 Dec; 55(3 Pt 1):427-32. PubMed ID: 7835783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment proliferation parameters do not add predictive power to clinical factors in cervical cancer treated with definitive radiation therapy.
    Tsang RW; Juvet S; Pintilie M; Hill RP; Wong CS; Milosevic M; Chapman W; Levin W; Manchul LA; Fykes AW
    Clin Cancer Res; 2003 Oct; 9(12):4387-95. PubMed ID: 14555510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radical hysterectomy for stage IB1 vs IB2 carcinoma of the cervix: does the new staging system predict morbidity and survival?
    Finan MA; DeCesare S; Fiorica JV; Chambers R; Hoffman MS; Kline RC; Roberts WS; Cavanagh D
    Gynecol Oncol; 1996 Aug; 62(2):139-47. PubMed ID: 8751541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.